Cancer Antigen 19.9 - Pancreatic Cancer Marker Test in Chittaranjan Park, Delhi

Kalkaji, Delhi
1250.0 for Cancer Antigen 19.9 - Pancreatic Cancer Marker
Open today  ·  See all timings
Call
#M-76AA, Greater Kailash-II, Landmark: Near M Block Market, Delhi
1250.0 for Cancer Antigen 19.9 - Pancreatic Cancer Marker
Open today  ·  See all timings
Call
Kalkaji, Delhi
1250.0 for Cancer Antigen 19.9 - Pancreatic Cancer Marker
Closed today
Call
NABL, Accredited
# E - 262, Basement, Greater Kailash Part 1, Delhi
Home sample pickup available · 1250.0 for Cancer Antigen 19.9 - Pancreatic Cancer Marker
Open today  ·  See all timings
Call
F 25, Ring Road, Lajpat Nagar - III, Delhi
1250.0 for Cancer Antigen 19.9 - Pancreatic Cancer Marker
Open today  ·  See all timings
Call
Malviya Nagar, Delhi
1250.0 for Cancer Antigen 19.9 - Pancreatic Cancer Marker
Open today  ·  See all timings
Call
Malviya Nagar, Delhi
1250.0 for Cancer Antigen 19.9 - Pancreatic Cancer Marker
Open today  ·  See all timings
Call
NABL CAP, Accredited
Malviya Nagar, Delhi
Home sample pickup available · 1250.0 for Cancer Antigen 19.9 - Pancreatic Cancer Marker
Open today  ·  See all timings
Call
B-31,Shivalik, Panchsheel-Shivalik Main Road, Landmark: Near Aurobindo College, Delhi
800.0 for Cancer Antigen 19.9 - Pancreatic Cancer Marker
Open today  ·  See all timings
Call
Saket, Delhi
1250.0 for Cancer Antigen 19.9 - Pancreatic Cancer Marker
Open today  ·  See all timings
Call
About Cancer Antigen 19.9 - Pancreatic Cancer Marker Test

Pancreatic cancer is an aggressive tumor with the characteristic of dismal prognosis. The biomarkers which detect the tumor at early stage might be helpful in the terms of improving the prognosis. As of now only, serum CA 19-9 is the validated marker for the clinical use to check the presence of tumor. Serum CA 19-9 is used for the detection of the tumor. Pancreatic cancer is one of the widespread cancers leading to death of the peoples worldwide. The lethal nature and aggressiveness of the disease can be predicted by the fact that the death rate by pancreatic cancer is equivalent to the mortality rate. A revelation has been made from a population based survey that the survival chances in case of advanced pancreatic cancer is 5 years of 4-6 percent patients surfing from the disease. In 1979, Koprowski et al. used hybridoma technology and identified carbohydrate antigen 19-9, i.e., CA 19-9, which recognises sialo ganglioside with the use of monoclonal antibody, named, 1116-NS-19-9.

More about this test
Why is this test required?
Why are normal values?
What is the general cost of this test?
TOP OF PAGE
x
Stay updated with the latest health tips from doctors!
Looks like you've blocked notifications!